Skip to content
PICO Portalanswers from OpenAlex

Overexpression of EIF‐5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder

PaperCitations, authors & open-access status

Overexpression of EIF‐5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder is a paper indexed in PICO Portal from OpenAlex.

How many citations does Overexpression of EIF‐5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder have?

PICO Portalcitation count

Overexpression of EIF‐5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder has 36 citations in the OpenAlex counts PICO Portal stores.

When was Overexpression of EIF‐5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder published?

PICO Portalyear

Overexpression of EIF‐5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder has 2009 year in the PICO Portal index.

What is the open-access status of Overexpression of EIF‐5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder?

PICO Portaloa status

Overexpression of EIF‐5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder has green oa status in the PICO Portal index.

What is the DOI of Overexpression of EIF‐5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder?

PICO Portaldoi

The DOI for Overexpression of EIF‐5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder is on the source record.

What is the PMID of Overexpression of EIF‐5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder?

PICO Portalpmid

The PMID for Overexpression of EIF‐5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder is on the source record.

What is the OpenAlex record for Overexpression of EIF‐5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder?

PICO Portalopenalex

The OpenAlex for Overexpression of EIF‐5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial